Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Hinokitiol Inhibits Breast Cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- المؤلفون: Chiang, Yi-Fen1 (AUTHOR) ; Huang, Ko-Chieh1 (AUTHOR) ; Chen, Hsin-Yuan1 (AUTHOR) ; Hamdy, Nadia M.2 (AUTHOR) ; Huang, Tsui-Chin3 (AUTHOR) ; Chang, Hsin-Yi4 (AUTHOR) ; Shieh, Tzong-Ming5 (AUTHOR); Huang, Yun-Ju6 (AUTHOR) ; Hsia, Shih-Min1,7,8,9,10 (AUTHOR)
- المصدر:
International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3904. 15p.
- الموضوع:
- معلومة اضافية
- نبذة مختصرة :
Breast cancer (BC) represents one of the most prevalent malignant threats to women globally. Tumor relapse or metastasis is facilitated by BC stemness progression, contributing to tumorigenicity. Therefore, comprehending the characteristics of stemness progression and the underlying molecular mechanisms is pivotal for BC advancement. Hinokitiol (β-thujaplicin), a tropolone-related compound abundant in the heartwood of cupressaceous plants, exhibits antimicrobial activity. In our study, we employed three BC cell lines (MDA-MB-231, MCF-7, and T47D) to assess the expression of stemness-, apoptosis-, and autophagy-related proteins. Hinokitiol significantly reduced the viability of cancer cells in a dose-dependent manner. Furthermore, we observed that hinokitiol enhances apoptosis by increasing the levels of cleaved poly-ADP-ribose polymerase (PARP) and phospho-p53. It also induces dysfunction in autophagy through the upregulation of LC3B and p62 protein expression. Additionally, hinokitiol significantly suppressed the number and diameter of cancer cell line spheres by reducing the expression of cluster of differentiation44 (CD44) and key transcription factors. These findings underscore hinokitiol's potential as a therapeutic agent for breast cancer, particularly as a stemness-progression inhibitor. Further research and clinical studies are warranted to explore the full therapeutic potential of hinokitiol in the treatment of breast cancer. [ABSTRACT FROM AUTHOR]
No Comments.